It’s Day 2 of the #DiabetesTechnologyMeeting! Thank you to everyone who attended Orange Biomed’s abstract presentation last night; we were pleased to connect with Nada Haboudal, Timothy Bailey, Muhammad Mujeeb-U-Rahman, and others to showcase our innovative A1C testing method. Our abstract presentation offered a detailed overview of the microfluidic components of OBM rapid A1c, discussing their capabilities in improving traditional test methods. Today, our team attended David Kerr MD’s presentation on Nutrition Monitoring for Diabetes which discussed how there are large variations across individuals and highlighted the importance of accurate testing solutions. We also heard from Anthony Maiorana, who shared the FDA’s current views and regulatory approaches for assessing new technologies and innovative devices. Missed our presentation yesterday? Visit the Startup Showcase tonight from 5:00-7:00 p.m. to see the world’s first microfluidic-based A1C test in person. Tomorrow is the last day of DTM! Don't miss the chance to meet our team and learn more about our new breakthrough method of testing A1C. Reach out to our team to book a media interview or meeting (in-person or virtual): shannon@orangebiomed.com #DiabetesTechnology #DiabetesTech #DiabetesTechnologySociety #A1C #A1CTesting #MicrofluidicTechnology #DiabetesTechnologyMeeting #DTM24
Orange Biomed’s Post
More Relevant Posts
-
🚨 Revolutionize your blood products preparation 🚨 SHMC Medical Technologies is thrilled to introduce the C-LAB Automate by Acemis France, a cutting-edge device designed to streamline and secure sterile connection testing for blood banks and healthcare facilities. ✨ What is C-LAB? C-LAB is the ultimate solution for testing the airtightness of sterile welded tubings (1 to 6 connections) with precision and efficiency. Fully compliant with EU directives, it’s the trusted choice for professionals who demand reliability and performance. 💡 Why choose C-LAB? ✅ Automated reliability: Standardized and reproducible results every time. 📊 Comprehensive traceability: Barcode scanning ensures detailed tracking of unit numbers, blood product types, and operators, with printable reports. 🖥️ User-friendly design: Intuitive 4-step process and touchscreen interface for effortless operation. ⏱️ Efficiency boost: Cuts testing time by more than 50%, freeing operators for other tasks. 🏆 Proven performance: Successfully validated through 6,213 tests by EFS Bourgogne/Franche-Comté. 🌍 Fully compliant with European guidelines, C-LAB meets the strictest standards, ensuring unmatched quality and safety for blood product preparation. ➡️You want to discover how C-LAB can elevate your operations ? 📩Reach out today: info@shmc.be #MedicalTechnology #HealthcareInnovation #BloodBanking #SHMC #CLAB #ACEMIS
-
-
Introducing Genesign HBsAg Rapid Test! 🚀 ✅ detect HBsAg at concentrations as low as 0.5ng/mL (1.0 IU/mL). ✅ Uncut sheet is available to supply if needed. Trust Genesign for reliable medical diagnostics. #HBsAgTest #MedicalDiagnostics #RapidTesting #Genesign
-
-
US HCPs: #MIDWAY 62 tracking proximal to ICA terminus aneurysm to support #SMART coil embolization then Pipeline 3.5x18 deployment. System was supported by #BMX96 in proximal ICA. Courtesy of Dr. Robert Starke! Rx only. Risk: peninc.info/risk Clinical results may vary
-
Founder & CEO, Ascent Strategy Group | Digital Health Evangelist I Reputation Management Counselor | Reinvention Strategist | Independent Film Producer | Believer in Better Outcomes for All
A pivotal stride announced today to address the growing AFib epidemic. The FDA has granted OMRON Healthcare, Inc. its De Novo authorization to market new home blood pressure monitors featuring breakthrough AI-powered atrial fibrillation detection. OMRON is making AFib screening a more integral part of their blood pressure monitoring experience as part of the company's Going for Zero mission to eliminate heart attack and stroke. AFib is a serious condition that is under-discussed, under-checked and underdiagnosed. OMRON wants to change that. This is a medical device first. OMRON’s novel machine learning IntelliSense AFib algorithm automatically analyzes the Pressure Pulse Wave generated during blood pressure measurement to detect AFib with every blood pressure monitoring experience. OMRON executives announced the De Novo authorization today as the company prepares to participate in the American Heart Association Scientific Sessions in Chicago this weekend. Conor Hale and Fierce Biotech have the story. https://lnkd.in/gPN7gt3u #OMRON #GoingforZero #AFib #FDA #DeNovo #AFibdetection #bloodpressuremonitors #medicaldevices #healthAI #digitalhealth #AHA24
-
-
📱OMRON Healthcare, Inc. gets FDA De Novo authorisation for AI-powered BP monitors The company designed the new blood pressure monitors featuring advanced AI-powered atrial fibrillation detection capabilities to address the growing AFib epidemic. Its IntelliSense AFib machine-learning algorithm automatically analyses the Pressure Pulse Wave generated during blood pressure measurement to detect AFib, which causes stroke. OMRON Healthcare is offering the AI-powered AFib screening solution as part of its ‘Going for Zero’ initiative aimed at preventing heart attack and stroke. Read more online: https://lnkd.in/eSiM2JUf 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing
-
-
🏥 Sensome announces positive results for Clotild guidewire in PAD studies The system demonstrated its ability to successfully identify fresh clots, rich in red blood cells (RBC), during the SEPARATE and E-SEPARATE studies. It also differentiated these clots from other tissues during PAD procedures. The Clotild clot-sensing guidewire is said to combine the world’s smallest electrical impedance sensor with machine learning. It has received breakthrough status from the US Food and Drug Administration (FDA). The guidewire is designed to identify fresh clots and differentiate it from organised clots, plaque, calcium, and other tissues during PAD procedures. This real-time technology aims to support personalised PAD treatment. Read more online: https://lnkd.in/eEBR4N9c 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing
-
-
🚀 Sneak Peek Alert! IVY Diagnostics is about to unveil its latest technological marvel at the Cosmofarma Exhibition the A1c Go Point-of-Care Glycated Hemoglobin Analyzer! A1c Go is more than just a diagnostic tool; it's a reliable companion for delivering quality care quickly and efficiently. Here's what makes it so special: 🔍 Advanced Technique: It employs affinity chromatography with boronates, ensuring accurate and stable analyses. 🤖 Automatic Operation: Complete in a single step, making analysis quick and seamless. ⏱️ Fast Results: Get precise results in just minutes, enabling timely care. 🚫 No Liquid Pathway: With this feature, there are no issues of carryover, and maintenance is kept to a minimum. 🔄 Minimal Interference: Hb variants have minimal impact on results, ensuring maximum accuracy. 💼 Suitable for Any Setting: Usable in hospital labs, medical clinics, and more, making primary care timely and accessible. With A1c Go, diagnosing and monitoring glycated hemoglobin becomes easier than ever, allowing medical professionals to focus on their patients' health. Learn more at the IVY Diagnostics booth 29 STAND A 24 at the Cosmofarma fair! #A1cGo #IVYDiagnostics #Cosmofarma #farmacia #farmacy #lab #primarycare #rapiddiagnostics
-
Unlocking the secrets of blood clotting with our latest factor assay for ADAMTS13. Precision in every test. #BloodScience #ADAMTS13 #medicalbreakthrough #iracom #medical #compactdiagnostics #healthtech #compactdiagnosticsindia #diagnosticexcellence #medicalinnovation
-
Unlocking the secrets of blood clotting with our latest factor assay for ADAMTS13. Precision in every test. #BloodScience #ADAMTS13 #medicalbreakthrough #iracom #medical #compactdiagnostics #healthtech #compactdiagnosticsindia #diagnosticexcellence #MedicalInnovation
-
💡 #IABP and iVAL2L Mechanism of Action & Clinical Data. Chapter 13.1 of our #SCAIMCSebook explores how the IABP and iVAC2L devices support circulation, reduce afterload, and enhance coronary perfusion in #CardiogenicShock or #CS. Learn more about their clinical applications and current data. 📚 #MCS 🔗 https://ow.ly/YqaZ50UFIZh
-
